Anti Inflammatory Treatment of Hypertension
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT04740840
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 200 participants
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Registry
-
NCT04740840
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT04740840. Randomized; single masking; primary purpose treatment. Start 2010-05-01 (actual); primary completion 2012-04-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Anti Inflammatory Treatment of Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- Levamlodipine
- Intervention (Drug)
- Amlodipine
- Lead sponsor
- Affiliated Hospital of North Sichuan Medical College
- Collaborator
- First Hospitals affiliated to the China PLA General Hospital
Record details
- Record id
cardio:ct-nct04740840- Content hash
5943cbb6a16255b551adc674b7fd1bf1d05a49d925fd46deb41c4984ea3c0d8e